LncRNAWiki:Featured

|HSALNT0267755 |LINC02597 |Transcriptional regulation |_ |Pathogenic process |Postmenopausal osteoporosis (PMOP) |Musculoskeletal Diseases |- |HSALNT0178412 |UVRAG-DT |Transcriptional regulation |_ |Pathogenic process |Postmenopausal osteoporosis (PMOP) |Musculoskeletal Diseases |- |HSALNT0185540 |LINC02598 |_ |_ |Pathogenic process |Lung squamous cell carcinoma (LUSC) |Neoplasms; Respiratory Tract Diseases |- |HSALNT0278274 |SREBF2-AS1 |_ |_ |Pathogenic process |Lung squamous cell carcinoma (LUSC) |Neoplasms; Respiratory Tract Diseases |- |HSALNT0021177 |LINC02602 |_ |_ |Pathogenic process |Non-small cell lung cancer (NSCLC)  |Neoplasms; Respiratory Tract Diseases |- |HSALNT0021052 |MIR205HG |CeRNA |_ |Pathogenic process |Head & neck squamous cell carcinoma (HNSCC) |Neoplasms |- |HSALNT0107588 |ZNF451-AS1 |Transcriptional regulation |_ |Pathogenic process |Pancreatic ductal adenocarcinoma (PDAC) |Neoplasms |- |HSALNT0189537 |SCAT2 |_ |_ |Pathogenic process |Kidney clear cell carcinoma (KIRC) |Neoplasm |- |HSALNT0107867 |SCAT8 |_ |_ |Pathogenic process |Kidney clear cell carcinoma (KIRC) |Neoplasm |- |HSALNT0158500 |LINC00707 |Transcriptional regulation |_ |Pathogenic process |Lung cancer (LC)  |Neoplasms; Respiratory Tract Diseases |- |HSALNT0185476 |LINC02470 |_ |_ |Pathogenic process |Non-small cell lung cancer (NSCLC) and overian cancer |Neoplasm |- |HSALNT0068302 |LINC02600 |_ |_ |Pathogenic process |Non-small cell lung cancer (NSCLC) and overian cancer |Neoplasm |- |HSALNT0123915 |LINC02604 |CeRNA |_ |Pathogenic process |Glioblastoma |Neoplasms |- |HSALNT0160932 |MACORIS |Transcriptional regulation |_ |_ |Cardiometabolic Diseases |Cardiovascular Diseases |- |HSALNT0171022 |KRTAP5-AS1 |CeRNA |_ |Pathogenic process |Gastric Cancer |Neoplasms; Digestive System Diseases |- |HSALNT0215076 |GSC-DT |_ |_ | Developmental process |_ |_ |- |HSALNT0072605 |CHAER1 |Translational control |_ |Pathogenic process |Cardiac hypertrophy |Cardiovascular Diseases |- |HSALNT0027291 |ODC1-DT |CeRNA |_ |Pathogenic process |Head and neck carcinoma  |Neoplasm |- |HSALNT0039409 |MAP3K2-DT |_ |_ |Pathogenic process |Polycystic ovary syndrome (PCOS) |Female Urogenital Diseases and Pregnancy Complications |- |HSALNT0208284 |ZFHX2-AS1 |Transcriptional regulation |_ |Developmental process |_ |_ |- |HSALNT0152349 |LINC02603 |_ |_ |_ |_ |_ |- |HSALNT0081596 |TENM3-AS1 |_ |_ |_ |_ |_ |- |HSALNT0165522 |LINC00858 |_ |_ |_ |non-small cell lung cancer | Respiratory Tract Diseases |- |HSALNT0281930 |SCAT1 |_ |_ |_ |esophagal cancer |Digestive system Diseases |- |HSALNT0191750 |LNCOG |_ |_ |_ |osteogenic differenciation |Musculoskeletal Diseases |- |HSALNT0246388 |DCXR-DT |_ |_ |_ |prostate cancer |Male Urogenital Diseases |- |HSALNT0209659 |NKX2-1-AS1 |_ |_ |_ |lung cancer | Respiratory Tract Diseases |- |HSALNT0038250 |ACTR3-AS1 |_ |_ |_ |glioblastoma |Nervous system diseases |- |HSALNT0043145 |ITGA6-AS1 |_ |_ |_ |glioblastoma |Nervous system diseases |- |HSALNT0281822 |LINC02601 |_ |_ |_ |glioblastoma |Nervous system diseases |- |_ |ZKSCAN7-AS1 |_ |_ |_ |glioblastoma |Nervous system diseases |- |HSALNT0120721 |GARS-DT |_ |_ |_ |heroine addiction |Nervous system diseases |- |HSALNT0093136 |LINCADL |_ |_ |_ |obesity |Digestive system Diseases |- |_ |GPRACR |_ |_ |_ |liver cancer |Digestive system Diseases |- |HSALNT0082561 |LINC01060 |_ |_ |_ |pancreatic cancer |Digestive system Diseases |- |HSALNT0058704 |TBILA |_ |_ |_ |non-small cell lung cancer | Respiratory Tract Diseases |- |_ |UGDH-AS1 |_ |_ |_ |invertebral disc degeneration |Musculoskeletal Diseases |- |HSALNT0245777 |TNRC6C-AS1 |_ |_ |_ |Thyroid cancer |Endocrine system Disease |- |HSALNT0225753 |LINC02244 |_ |_ |_ |obesity |Digestive system Diseases |- |_ |NKAIN3-IT1 |_ |_ |_ |glioblastoma |Nervous system diseases |- |HSALNT0013113 |NGF-AS1 |_ |_ |_ |dysmenorhea |Female Urogenital Diseases |- |HSALNT0031057 |LINC01121 |_ |_ |_ |pancreatic cancer |Digestive system Diseases |- |HSALNT0234176 |ARLNC1 |_ |_ |_ |prostate cancer |Male Urogenital Diseases |- |_ |MPPED2-AS1 |_ |_ |_ |thyroid neoplasias |Endocrine system Disease |- |_ |ZKSCAN2-DT |_ |_ |_ |Hepatocellular carcinoma |Digestive system Diseases |- |_ |LINC01703 |_ |_ |_ |Hepatocellular carcinoma |Digestive system Diseases |- |HSALNT0144162 |HPYR1 |_ |_ |pathogenic process |H. pylori infection |_ |- |HSALNT0172266 |LINC00958 |protein localization,transcriptional regulation |_ |pathogenic process |bladder cancer, glioma |_ |- |HSALNT0167574 |SH3PXD2A-AS1 |transcriptional regulation |_ |pathogenic process |colorectal cancer |_ |- |_ |SSTR5-AS1 |transcriptional regulation |_ |pathogenic process |neuroendocrine prostate cancer |_ |- |_ |TSPOAP1-AS1 |_ |_ |pathogenic process |breast cancer |_ |- |_ |LINC00174 |ceRNA |_ |pathogenic process |colorectal carcinoma |_ |- |HSALNT0169064 |LINC01561 |ceRNA |_ |pathogenic process |breast cancer |_ |- |_ |LINC00514 |transcriptional regulation |_ |pathogenic process |neuroendocrine prostate cancer |_ |- |HSALNT0282164 |LINC02595 |_ |_ |pathogenic process |colorectal cancer |_ |- |HSALNT0197396 |FZD10-AS1 |_ |_ |_ |_ |_ |- |_ |LINC01567 |transcriptional regulation |_ |pathogenic process |colon cancer |_ |- |_ |ADPGK-AS1 |transcriptional regulation |_ |pathogenic process |pancreatic cancer |_ |- |HSALNT0255381 |RAB11B-AS1 |transcriptional regulation |_ |pathogenic process |osteosarcoma |_ |- |HSALNT0237805 |SNHG29 |transcriptional regulation |_ |pathogenic process |acute myeloid leukemia, rheumatoid arthritis |_ |- |_ |SNHG17 |transcriptional regulation |_ |pathogenic process |colorectal cancer |_ |- |HSALNT0215138 |DICER1-AS1 |transcriptional regulation |_ |pathogenic process |osteosarcoma |_ |- |HSALNT0043929 |TTN-AS1 |transcriptional regulation |_ |pathogenic process |esophageal squamous cell carcinoma |_ |- |HSALNT0152594 |LINC00092 |transcriptional regulation |_ |pathogenic process |ovarian cancer |_ |- |HSALNT0050704 |THUMPD3-AS1 |transcriptional regulation |_ |pathogenic process |Neuron death in stroke |_ |- |HSALNT0205980 |LINC00554 |transcriptional regulation |_ |pathogenic process |liver cancer |_ |- |HSALNT0141703 |ZFPM2-AS1 |transcriptional regulation |_ |pathogenic process |multiple cancers, gastric carcinogenesis |_ |- |_ |HOXB-AS1 |transcriptional regulation |_ |pathogenic process |autosomal dominant polycistic kidney disease |_ |- |HSALNT0167650 |CFAP58-DT |transcriptional regulation |_ |pathogenic process |innate immune response to viral infection |_ |- |_ |FAM230A |_ |_ |_ |_ |_ |- |_ |CPNE8-AS1 |transcriptional regulation |_ |pathogenic process |cervical cancer |_ |- |_ |THORLNC |transcriptional regulation |_ |pathogenic process |melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma |_ |- |_ |IATPR |transcriptional regulation |_ |pathogenic process |breast cancer, gallbladder cancer |_ |- |HSALNT0242280 |PICART1 |transcriptional regulation |_ |pathogenic process |breast cancer, colorectal cancer, lung cancer |_ |- |_ |LINC02599 |transcriptional regulation |_ |pathogenic process |breast cancer |_ |- |HSALNT0183231 |ETS1-AS1 |transcriptional regulation |_ |pathogenic process |gastric cancer, neuroblastoma |_ |- |_ |MAPK6-DT |transcriptional regulation |_ |pathogenic process |liver cancer |_ |- |HSALNT0036655 |IL1R1-AS1 |transcriptional regulation |_ |pathogenic process |Oral squamous cell carcinoma, breast cancer |_ |- |HSALNT0001134 |LINC01672 |transcriptional regulation |_ |pathogenic process | Esophageal squamous cell carcinoma |_ |- |HSALNT0135857 |SIRLNT |ceRNA |_ |pathogenic process | Breast cancer |_ |- |HSALNT0135484 |LINC01605 |transcriptional regulation |_ |pathogenic process |Colon Cancer, Bladder cancer |_ |- |HSALNT0184552 |GAU1 |transcriptional regulation |_ |pathogenic process |Neuroblastoma and retinoblastoma |_ |- |HSALNT0287294 |LINC00894 |transcriptional regulation |_ |pathogenic process |Lung adenocarcinoma |_ |- |HSALNT0000250 |LINC02593 |_ |_ |pathogenic process |breast cancer, hepatocellular carcinoma |_ |- |HSALNT0241060 |LINC02594 |_ |_ |_ |gastric cancer |_ |- |HSALNT0022481 |LINC01705 |transcriptional regulation |_ |pathogenic process |gastric cancer |_ |- |HSALNT0022477 |LINC02474 |transcriptional regulation |_ |pathogenic process |gastric cancer |_ |- |HSALNT0030809 |LINC02590 |transcriptional regulation |_ |pathogenic process |gastric cancer |_ |- |HSALNT0170966 |MUC5B-AS1 |transcriptional regulation |_ |pathogenic process | lung adenocarcinoma |_ |- |HSALNT0275151 |FAM230D |_ |_ |_ |_ |_ |- |HSALNT0275163 |FAM230E |_ |_ |_ |_ |_ |- |HSALNT0275179 |FAM230F |_ |_ |_ |_ |_ |- |_ |FAM230G |_ |_ |_ |_ |_ |- |_ |FAM230H |_ |_ |_ |Papillary thyroid carcinoma |_ |- |_ |FAM230I |_ |_ |_ |_ |_ |- |HSALNT0275150 |FAM230J |_ |_ |_ |_ |_ |- |HSALNT0103387 |HCG14 |transcriptional regulation |_ |pathogenic process |Celiac disease, Nutritional and Metabolic Diseases |_ |- |HSALNT0001419 |LNCTAM34A |ceRNA |_ |developmental process |Colon Cancer |_ |- |_ |LINC01510 |transcriptional regulation, ceRNA |_ |pathogenic process |Colorectal cancer, Non-small cell lung cancer |_ |- |_ |LNCOC1 |transcriptional regulation |_ |pathogenic process |Ovarian cancer |_ |- |_ |LGALSL-DT |transcriptional regulation |_ |pathogenic process |Postmenopausal osteoporosis (PMOP) |_ |- |HSALNT0002862 |LINC02596 |transcriptional regulation |_ |pathogenic process |Postmenopausal osteoporosis (PMOP) |_ |-

|_ |DEC1 |_ |_ |_ |_ |_ |_ |RN7SK |_ |_ |_ |_ |_ |_ |RN7SL1 |_ |_ |_ |_ |_ |_ |MYOPARR |_ |_ |_ |_ |_ |_ |PCED1B-AS1 |_ |_ |_ |_ |_ |_ |UMLILO |_ |_ |_ |_ |_ |_ |LINC02631 |_ |_ |_ |_ |_ |_ |BMNCR |_ |_ |_ |_ |_ |_ |ZEBTR |_ |_ |_ |_ |_ |_ |SNHG31 |_ |_ |_ |_ |_ |_ |ILF3-DT |_ |_ |_ |_ |_ |_ |LINC00574 |_ |_ |_ |_ |_ |_ |CEBPA-DT |_ |_ |_ |_ |_ |_ |BABAM2-AS1 |_ |_ |_ |_ |_ |_ |[[]] |_ |_ |_ |_ |_ |_ |SNHG30 |_ |_ |_ |_ |_ |_ |RCC2-AS1 |_ |_ |_ |_ |_ |_ |NIPBL-DT |_ |_ |_ |_ |_ |_ |PRDM16-DT |_ |_ |_ |_ |_ |_ |BCL6-AS1 |_ |_ |_ |_ |_ |_ |C1orf220 |_ |_ |_ |_ |_ |_ |MIR122HG |_ |_ |_ |_ |_ |_ |RB1-DT |_ |_ |_ |_ |_ |_ |PANTR1 |_ |_ |_ |_ |_ |_ |C11orf72 |_ |_ |_ |_ |_ |_ |CT66 |_ |_ |_ |_ |_ |_ |CAPN10-DT |_ |_ |_ |_ |_ |_ |MIR1915HG |_ |_ |_ |_ |_ |_ |CT75 |_ |_ |_ |_ |_ |_ |[[]] |_ |_ |_ |_ |_ |_ |MIR9-3HG |_ |_ |_ |_ |_ |_ |RN7SL2 |_ |_ |_ |_ |_ |_ |RN7SL3 |_ |_ |_ |_ |_ |_ |CT70 |_ |_ |_ |_ |_ |_ |CT69 |_ |_ |_ |_ |_ |_ |FLVCR1-DT |_ |_ |_ |_ |_ |_ |C10orf91 |_ |_ |_ |_ |_ |_ |CEP83-DT |_ |_ |_ |_ |_ |_ |CSTF3-DT |_ |_ |_ |_ |_ |_ |CTBP1-DT |_ |_ |_ |_ |_ |_ |FAM201B |_ |_ |_ |_ |_ |_ |MAFG-DT |_ |_ |_ |_ |_ |_ |RPP38-DT |_ |_ |_ |_ |_ |_ |CDRT3 |_ |_ |_ |_ |_ |_ |DLEU2L |_ |_ |_ |_ |_